FEATURED EDITORIAL
According to a recent poll, 45% of participants believe the NAMs industry should expand pre-competitive consortia by sharing validation data and best practices to reduce duplication and accelerate acceptance. Experts Zahar Nahle, Ph.D. and Samantha Atkins, Ph.D. share their insights.
- How Can We Develop New Treatments For Patients With Early Breast Cancer?
- When One Gene Isn't Enough: The Case For Gene-Agnostic Vision Rescue
- Notes From A VC: What It Takes To Be Impactful In Longevity Science
- Protein Degraders Redefine ADME And Drug Disposition Dynamics
- OpenFold3 Released: Redefining The Limits Of Protein Prediction Models
- Returning To Nature: Discovering The Next Generation Of Medicines
- How The U.S. Can Beat China In Biotech
FEATURED APPLICATION CONTENT
-
Explore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
Explore how particle levels remained stable during 24 hours of high-speed mixing, even under extreme temperatures, confirming a system’s suitability for final fill and other particulate-sensitive applications.
-
Explore how a modular AAV8 platform enables scalable, GMP-ready gene therapy manufacturing with reproducible outcomes, streamlined tech transfer, and adaptability across serotypes.
-
Discover how a CDMO achieved 40x productivity and 15% cost savings by switching to rapid cycling membrane chromatography for ADC polishing, which helped cut process time and buffer use.
-
Continuous biomanufacturing is reshaping how active pharmaceutical ingredients are produced. Learn how modular, automated virus inactivation solutions are helping manufacturers improve efficiency.
-
Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.
-
Gain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.
-
Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.
-
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
-
Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing.
-
Cell therapy’s future depends on smarter gene delivery. Learn how lipid nanoparticles offer a scalable, cell-friendly alternative to electroporation and viral vectors for manufacturing efficiency.
-
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
- Live Insights: 45% Believe The NAMs Industry Should Expand Pre-Competitive Data Sharing Programs
- OpenFold3 Released: Redefining The Limits Of Protein Prediction Models
- Video Spotlight: Where Science Meets Magic with MIT Institute Professor Robert S. Langer
- Discovery On Hold: How Shutdowns Stall Science And Shake Trust
- Tyra Crystallizing The First Oral FGFR3 Therapy For Achondroplasia
FEATURED NEWS HEADLINES
- BullFrog AI To Present bfPREP At The AI Drug Discovery & Development Summit 2025
- BenchSci And Mila Partner To Advance AI For Biological Inference And Accelerate Drug Discovery
- BostonGene And Kyoto University Partner To Accelerate Precision Drug Development
- Avenzo Therapeutics Granted Fast Track Designation For AVZO-1418, A Potential Best-In-Class EGFR/HER3 Bispecific Antibody-Drug Conjugate, For The Treatment Of Patients With EGFR-Mutated TKI-Pretreated NSCLC
- Why Creative Biolabs Is Betting On AI-Driven Chemical Synthesis To Accelerate Drug Innovation
- Insilico And Lilly Enter A Research & Licensing Collaboration To Advance AI-Driven Drug Discovery
- Harbour BioMed And Evinova China Announce Strategic AI Collaboration To Accelerate AI-Enabled Drug Development
- MavriX Bio Announces First Patient Dosed In ASCEND-AS Trial Of MVX-220, Investigational Gene Therapy For Angelman Syndrome
- Arcturis And Royal Berkshire NHS Foundation Trust Enter Strategic Partnership
- NanoTemper Strengthens Biopharma Discovery Portfolio With Acquisition Of Envue Technologies And Launch of Dianthus™ α
ARCHIVED NEWSLETTER
- 11.12.25 -- Redefining API Manufacturing Through Continuous Innovation
- 11.11.25 -- OpenFold3 Redefining The Limits Of Protein Prediction Models
- 11.07.25 -- Closing The Gap Between Discovery And Delivery
- 11.05.25 -- Amorphous Solid Dispersions: High Loading, Better Bioavailability, Smart Testing
- 11.04.25 -- Video Spotlight: Where Science Meets Magic with MIT Institute Professor Robert S. Langer